FDA
-
-
-
-
-
-
-
Implantica to host Capital Markets Day in Stockholm on September 9
-
-
-
-
-
-
-
Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesoph
-
-
-
-
-
-
-
Lunit partners with Agilent to develop AI companion diagnostic tools
-
-
-
-
-
-
-
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
-
-
-
-
-
-
-
Agilent Announces Cutting-Edge Advances in GC/MS and LC/Q-TOF Technology at ASMS 2024
-
-
-
-
-
-
-
Agilent Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/23: (AADI) (WDC) (MU) Higher; (BBY) (URBN) (ZM) Lower (more...)
-
336,722 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


